×
Join Our Mailing List
View 2025 Video Highlights
Testimonials
2025 Gallery Highlights

Celebrate 25 Years
of Innovation at PepTalk

Join a vibrant community of scientists, trailblazers, and industry leaders at PepTalk 2026, as we mark 25 years of accelerating breakthroughs in biotherapeutic discovery and development. Renowned as one of the most influential events in protein science, PepTalk is where fresh ideas ignite, collaborations flourish, and next-generation solutions take shape.

This year’s expanded agenda features symposia and conference tracks, covering protein expression, production platforms, lab automation for higher throughput, analytical characterization and preformulation strategies for novel modalities, antibody discovery and development, and new this year - expression and development of therapeutic peptides and miniproteins.

Gain insights from expert speakers, engage with a dedicated community, and leave with tools and strategies to move your research forward.

Experience four days of focused learning, expert-led sessions, poster presentations, keynotes, roundtables, panel discussions, exhibitions, and networking opportunities.

200 Presentations
200 Presentations
100 Posters
1000 Participants
75 Exhibitors

2025 PLENARY FIRESIDE CHAT


Navigating the Professional Landscape:

Strategic Pathways to Biotech Success

Deborah Moore-Lai

PANEL MODERATOR:
Deborah Moore-Lai, PhD, Vice President, Protein Sciences, ProFound Therapeutics

Emma Altman

PANELISTS:
Emma Altman, Sr. Research Associate, Protein Sciences, Kite, A Gilead Company

Henry C. Chiou

Henry C. Chiou, PhD, Sr. Director General Manager, Biosciences, Thermo Fisher Scientific (Retired)

Frances Maureen Rocamora

Frances Maureen Rocamora, PhD, Assistant Project Scientist, Pediatrics, University of California, San Diego

QC Yong

QC Yong, PhD, Antibody CMC, Associate Director, Capstan Therapeutics


ADDITIONAL 2025 KEYNOTE SPEAKERS INCLUDED:

Matthew DeLisa, PhD

Matthew DeLisa, PhD
Director, Cornell Institute of Biotechnology, Cornell University

Mary Jessel, PhD

Mary Jessel, PhD
Senior Vice President, Global Medical Affairs, Telix Pharmaceuticals

Hitoshi Katada, PhD

Hitoshi Katada, PhD
Head of Biologics Engineering, Research Division, Chugai Pharmaceutical Co. Ltd.

James D. Love, PhD

James D. Love, PhD
Vice President, Automation & Process Optimization, Novo Nordisk AS

Jay Sarkar, PhD

Jay Sarkar, PhD
Visiting Scholar, Stanford University

Sathya Venkataramani, PhD

Sathya Venkataramani, PhD
Associate Director, Biologics Discovery, Janssen Biotherapeutics

Jin Wang

Jin Wang
Director of Center for NextGen Therapeutics & Michael E. DeBakey, MD, Professor in Pharmacology, Baylor College of Medicine